We believe Cells can theoretically produce almost anything, from fabrics to food, fuel and medicines. Designing cell-factories is hard, but our tools and machine-learning models can make it easier. Our mission is to ultimately help replace traditional farms and factories for a more sustainable world.
Cradle has raised €97M across 3 funding rounds from 8 investors, most recently a Series B round in Nov 2024. Based in Amsterdam, Netherlands; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2024-11-26 | Series B | €69M | Index Ventures,IVP,Kindred Capital | View deal → |
| 2023-11-28 | Series A | €22M | Chris Gibson,Index Ventures,Kindred Capital,Tom Glocer | View deal → |
| 2022-11-17 | Seed | €5.3M | Emily Leproust,Feike Sijbesma,Index Ventures,John Zimmer,Kindred Capital | View deal → |
